Literature DB >> 16586130

[Hyperuricemia and gout: diagnosis and therapy].

A K Tausche1, S Unger, K Richter, C Wunderlich, J Grässler, B Roch, H E Schröder.   

Abstract

In our modern society hyperuricemia is one of the most frequent metabolism disturbances. So far, every fourth man and every tenth woman suffer from an asymptomatic or a symptomatic hyperuricemia named gout. Mostly, over nutrition and malnutrition as well as other secondary factors with a genetically determined renal secretion disturbance of uric acid lead to an increase of serum uric acid. By deposition of uric acid crystals in tissues with intermittent immunologic activation of inflammation cells a manifestation of gout can be seen. The clinical image of gout varies widely. It may manifest as acute or chronic arthritis, tophi on the skin, subcutaneous tissue and the skeletal system as well as urate nephropathy. To eliminate the consequences of hyperuricemia in the long term, apart from a thorough anamnesis of nutritional habits a general examination of metabolic parameters is necessary to exclude a metabolic syndrome and other causes for a secondarily caused hyperuricemia. As gout is very often primarily caused by a renal secretion disturbance of uric acid special diagnostics should be done. Basing on literature research and inclusion of experts opinions this article represents the therapeutically options in treatment of hyperuricemia and gout with their resulting side effects and contraindications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16586130     DOI: 10.1007/s00108-006-1578-y

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  21 in total

1.  [Hyperuricemia and gout--treatment].

Authors:  Wolfgang Gröbner; Ingeborg Walter-Sack
Journal:  Dtsch Med Wochenschr       Date:  2002-02-01       Impact factor: 0.628

Review 2.  Gout: diagnosis, pathogenesis, and clinical manifestations.

Authors:  C A Agudelo; C M Wise
Journal:  Curr Opin Rheumatol       Date:  2001-05       Impact factor: 5.006

Review 3.  [Hyperuricemia].

Authors:  W Gröbner; N Zöllner
Journal:  Internist (Berl)       Date:  1995-12       Impact factor: 0.743

4.  [The treatment of essential hyperuricemia in graduated programs].

Authors:  P Thiele; H E Schröder; E Runge
Journal:  Z Arztl Fortbild (Jena)       Date:  1984

Review 5.  Gout and hyperuricemia.

Authors:  Robert L Wortmann
Journal:  Curr Opin Rheumatol       Date:  2002-05       Impact factor: 5.006

6.  [Uric acid crystals and chemotactic cytokines--pathogenesis of an acute gout attack].

Authors:  P Peichl
Journal:  Wien Med Wochenschr       Date:  1997

7.  Loss of urate oxidase activity in hominoids and its evolutionary implications.

Authors:  Masako Oda; Yoko Satta; Osamu Takenaka; Naoyuki Takahata
Journal:  Mol Biol Evol       Date:  2002-05       Impact factor: 16.240

8.  Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency.

Authors:  K R Hande; R M Noone; W J Stone
Journal:  Am J Med       Date:  1984-01       Impact factor: 4.965

Review 9.  Uric acid transport.

Authors:  Mohammed A Rafey; Michael S Lipkowitz; Edgar Leal-Pinto; Ruth G Abramson
Journal:  Curr Opin Nephrol Hypertens       Date:  2003-09       Impact factor: 2.894

Review 10.  Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome.

Authors:  Michael B Davidson; Snehal Thakkar; John K Hix; Naveen D Bhandarkar; Alan Wong; Martin J Schreiber
Journal:  Am J Med       Date:  2004-04-15       Impact factor: 4.965

View more
  5 in total

Review 1.  [New aspects of the pathogenesis of gout. Danger signals, autoinflammation and beyond].

Authors:  P Lamprecht; A Till; D Kabelitz
Journal:  Z Rheumatol       Date:  2008-03       Impact factor: 1.372

2.  [Molecular basis of primary renal hyperuricemia : role of the human urate transporter hURAT1].

Authors:  S Unger; A-K Tausche; S Kopprasch; S R Bornstein; M Aringer; J Grässler
Journal:  Z Rheumatol       Date:  2007-11       Impact factor: 1.372

Review 3.  Gout--current diagnosis and treatment.

Authors:  Anne-Kathrin Tausche; Tim L Jansen; Hans-Egbert Schröder; Stefan R Bornstein; Martin Aringer; Ulf Müller-Ladner
Journal:  Dtsch Arztebl Int       Date:  2009-08-24       Impact factor: 5.594

4.  Conductimetric biosensor for the detection of uric Acid by immobilization uricase on nata de coco membrane-pt electrode.

Authors:  Ani Mulyasuryani; Arie Srihardiastutie
Journal:  Anal Chem Insights       Date:  2011-07-03

Review 5.  Neutrophils as Main Players of Immune Response Towards Nondegradable Nanoparticles.

Authors:  Rostyslav Bilyy; Galyna Bila; Oleg Vishchur; Volodymyr Vovk; Martin Herrmann
Journal:  Nanomaterials (Basel)       Date:  2020-06-29       Impact factor: 5.076

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.